Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;23(11):1577-80.
doi: 10.1007/s00192-012-1781-4. Epub 2012 Apr 25.

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study

Affiliations

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study

P Diamond et al. Int Urogynecol J. 2012 Nov.

Abstract

Introduction and hypothesis: Overactive bladder (OAB) is a symptom-based condition consisting of urgency, with or without incontinence, usually with frequency and nocturia. There are many potential causes of OAB, yet many patients are prescribed anticholinergic medications empirically. This study aimed to determine what proportion of patients presenting for urogynecologic assessment with symptoms of OAB had urodynamic detrusor overactivity (DO).

Methods: Retrospective chart review was performed for 220 consecutive patient referrals. Demographic data, physical exam information, and urodynamic results were collected. The t test and Fisher's exact test were used for statistical analyses.

Results: The prevalence of DO was 11.8 % in this population. Urogenital atrophy and incomplete emptying were more common. Patients with DO were older and more often menopausal than those without DO. Significant prolapse was a common finding amongst patients with OAB symptoms.

Conclusions: Patients with symptoms of OAB should undergo pelvic examination and assessment of post-void residuals before being initiated on anticholinergic medication.

PubMed Disclaimer

Comment in

References

    1. BJU Int. 2009 Jan;103(2):202-9 - PubMed
    1. N Engl J Med. 1989 Jan 5;320(1):1-7 - PubMed
    1. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(4):258-61 - PubMed
    1. Arch Gynecol Obstet. 2010 Jul;282(1):33-41 - PubMed
    1. Neurourol Urodyn. 2010;29(1):30-9 - PubMed

Publication types

Substances

LinkOut - more resources